TIL Desk/Business/Mumbai/ The Brihanmumbai Municipal Corporation has completed the second phase of clinical trials of the Oxford-AstraZeneca Covid-19 vaccine. The civic body will soon start third phase trials after the first batch of volunteers complete 28 days since their first vaccination.
The Brihanmumbai Municipal Corporation has completed the second phase of clinical trials of the Oxford-AstraZeneca Covid-19 vaccine. The civic body will soon start third phase trials after the first batch of volunteers complete 28 days since their first vaccination.
With the approval, we will be able to start the third phase of the trial once the first set of volunteers complete 28 days of the first vaccination. As per Indian Council of Medical Research, the third trial can only be conducted on volunteers after a gap of 28 days, said Suresh Kakani, additional commissioner, BMC.
On September 26, the first dosage of the second phase of trial was given to three volunteers between ages 20 and 45 years at KEM hospital. On October 23, they completed 28 days of their first vaccination.
